As for medications, there are significantly more patients taking anti-hypertensive agents, including calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACEi), and angiotensin receptor blockers (ARB) in the obesity group. This evidence concerns the gene ACE and obesity due to melanocortin 4 receptor deficiency.